1-1 of 1
M.J. Egorin
Close
Sort by
Journal Articles

Phase I Trial of Suberoylanilide Hydroxamic Acid (SAHA) + Bortezomib (Bort) in Relapsed Multiple Myeloma (MM) Patients (pts).

Ashraf Badros, S. Philip, R. Niesvizky, O. Goloubeva, C. Harris, J. Zweibel, J. Wright, A. Burger, S. Grant, M.R. Baer, M.J. Egorin
Journal: Blood
Blood (2007) 110 (11): 1168.
https://doi.org/10.1182/blood.V110.11.1168.1168
Published: 2007